You are viewing an incomplete version of our website. Please click to reload the website as full version.

Fc Fragment of IgG, Low Affinity IIa, Receptor (CD32) (FCGR2A) antibody

Details for Product No. ABIN1106262, Supplier: Log in to see
Antigen
  • CD32
  • CD32a
  • CD32A
  • CDw32
  • FCG2
  • FcGR
  • FCGR2
  • FCGR2A1
  • IGFR2
Reactivity
Dog (Canine), Human, Rhesus Monkey
178
7
6
6
3
2
1
Host
Mouse
115
73
1
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
12
12
11
6
4
4
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Application
Functional Studies (Func), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro)), Flow Cytometry (FACS), Immunoprecipitation (IP)
98
83
56
42
28
24
19
3
3
2
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen K562 cell line
Clone AT10
Isotype IgG1
Purification Affinity Chromatography on Protein A
Endotoxin Level Low Endotoxin
Alternative Name CD32 / FcRII-A (FCGR2A Antibody Abstract)
Background CD32 antigen is a 40 kD glycoprotein that acts as a low affinity receptor for IgG (also known as Fc gamma RII). The antigen mediates several functions including endocytosis, activation of secretion, cytotoxicity and immunomodulation. CD32 is expressed by B cells, monocytes, granulocytes and platelets.Synonyms: CDw32, FCG2, FCGR2A, FCGR2A1, Fc-gamma RII-a, Fc-gamma-RIIa, IGFR2, IgG Fc receptor II, Low affinity immunoglobulin gamma Fc region receptor II
Gene ID 2212
NCBI Accession NP_001129691
UniProt P12318
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Concentration 1.0 mg/mL
Buffer PBS without preservatives
Preservative Without preservative
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
Background publications Zhao, van Beek, Schornagel, Van der Maaden, Van Houdt, Otten, Finetti, Van Egmond, Matozaki, Kraal, Birnbaum, van Elsas, Kuijpers, Bertucci, van den Berg: "CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Issue 45, pp. 18342-7, 2011 (PubMed).

Araújo, de Andrade, Sathler-Avelar, Magalhães, Carvalho, Andrade, Campolina, Mello, Vianna, Mayrink, Reis, Malaquias, Rocha, Martins-Filho: "Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis." in: Veterinary immunology and immunopathology, Vol. 141, Issue 1-2, pp. 64-75, 2011 (PubMed).

Devriendt, Verdonck, Summerfield, Goddeeris, Cox: "Targeting of Escherichia coli F4 fimbriae to Fcgamma receptors enhances the maturation of porcine dendritic cells." in: Veterinary immunology and immunopathology, Vol. 135, Issue 3-4, pp. 188-98, 2010 (PubMed).

Santer, Hall, George, Tangsombatvisit, Liu, Arkwright, Elkon: "C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 185, Issue 8, pp. 4738-49, 2010 (PubMed).

Dutertre, Bonnin-Gélizé, Pulford, Bourel, Fridman, Teillaud: "A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent function." in: Journal of leukocyte biology, Vol. 84, Issue 6, pp. 1511-20, 2008 (PubMed).

Khan, Kim, Kim: "Synthesis and control of physical properties of titania nanoparticles as a function of synthetic parameters." in: Journal of nanoscience and nanotechnology, Vol. 8, Issue 9, pp. 4738-42, 2008 (PubMed).

Benitez-Ribas, Adema, Winkels, Klasen, Punt, Figdor, de Vries: "Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake." in: The Journal of experimental medicine, Vol. 203, Issue 7, pp. 1629-35, 2006 (PubMed).

Sims, Ettinger, Shirota, Yarboro, Illei, Lipsky: "Identification and characterization of circulating human transitional B cells." in: Blood, Vol. 105, Issue 11, pp. 4390-8, 2005 (PubMed).

Lilliehöök, Johannisson, Håkansson: "Expression of adhesion and Fcgamma-receptors on canine blood eosinophils and neutrophils studied by anti-human monoclonal antibodies." in: Veterinary immunology and immunopathology, Vol. 61, Issue 2-4, pp. 181-93, 1998 (PubMed).

Van Den Herik-Oudijk, Westerdaal, Henriquez, Capel, Van De Winkel: "Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 152, Issue 2, pp. 574-85, 1994 (PubMed).

Greenman, Tutt, George, Pulford, Stevenson, Glennie: "Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors." in: Molecular immunology, Vol. 28, Issue 11, pp. 1243-54, 1992 (PubMed).